LYMPHSCINTH

Nu mi-e clar cum se traduce asta in romaneste..Sentinel Lymph Node Biopsy! http://www.sfatulmedicului.ro/Investigatii/biopsia-sanului_1315 La pagina urmatoare se poate observa cum evolueaza neoplasmul prin invadarea peretelui ductal inspre primul nodul limfatic (sentinel)in care se scurge fluidul limfatic (care este filtrat de celule albe si lansat in restul corpului).De asemeni o imagine grafica pe timpul operatiei (atentie !): http://cancernews.com/data/Article/202.asp
 In cazul de fata acest nodul poate fi identificat prin trei metode de injectare in san efectuate in departamentul de medicina nucleara cu doua + ore inainte de biopsie : 1.cu substanta(tracer) radioactiva slaba, zic ei 2.cu substanta albastra(Mthylene blue sau Isosulfan blue) 3.o combinatie de 1 si 2
 Dupa injectie locul acumularii acestor substante va fi identificat sub forma de energie emisa de razele gamma si interpretate de un PET scanner, o camera gamma sau un detector Geiger.Imagini multiple ale sanului,pieptului si sub brat sunt capturate pe o durata de 30 minute - ore. Medicina nucleara este capabila sa identifice activitatea celulelor la nivel molecular (functie si structura)si astfel ofera sansa descoperirii unei boli in stagiu incipient,in cazuri fericite. Detalii despre lymphscint (scintigarame= imagini medicale ale sistemului limfatic capturate de gamma camera): http://www.radiologyinfo.org/en/info.cfm?pg=lympho < Titlul oficial al interventiei mele este: Left Intra-Operative Lymphatic mapping (IOML) with Sentinel Lymph Node Biopsy (SNLbx) iar explicatia procedurii este aici : http://www.dilon.com/surgical-products/navigator-gamma-probes/surgical-applications-and-probes/sentinel-lymph-node-biopsy-slnb/
 Biopsia asta determina implicarea nodulilor axiali ( de sub brat),adica metastaza. Intrebari inainte de interventie: A guideline was developed for the use of SLNB in early-stage breast cancer. The specific questions the guideline addressed were: 1. Can full axillary lymph node dissection be avoided in patients who have negative findings on SNLB? 2. Is full axillary lymph node dissection necessary for all patients with positive findings on SNLB? 3. What is the role of SNLB in special circumstances? 4. What factors affect the success of SNLB? 5. What are the potential benefits and harms associated with SNLB? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640353/